Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [6391]

Repurposed alcoholism drug fights liver cancer by targeting fat metabolism and blood supply

Repurposed alcoholism drug fights liver cancer by targeting fat metabolism and blood supply

Antibody-drug conjugate achieves high response rates as frontline treatment in aggressive, rare blood cancer

Antibody-drug conjugate achieves high response rates as frontline treatment in aggressive, rare blood cancer

FDA approves pembrolizumab with paclitaxel for platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal carcinoma

FDA approves pembrolizumab with paclitaxel for platinum-resistant epithelial ovarian, fallopian tube, or primary...

A bioadhesive patch inspired by mussel adhesion eliminates cells from the most aggressive brain tumour

A bioadhesive patch inspired by mussel adhesion eliminates cells from the most aggressive brain tumour

‘Sticky coat’ boosts triple negative breast cancer’s ability to metastasise

‘Sticky coat’ boosts triple negative breast cancer’s ability to metastasise

Researchers discover ABCA1 protein’s role in releasing molecular brakes on solid tumour immunotherapy

Researchers discover ABCA1 protein’s role in releasing molecular brakes on solid tumour immunotherapy

Dual-action molecule design concentrates cancer treatment in tumour cells to allow higher doses

Dual-action molecule design concentrates cancer treatment in tumour cells to allow higher doses

Killing cancer cells with RNA therapeutics

Killing cancer cells with RNA therapeutics

Blocking a key protein may create novel form of stress in cancer cells and re-sensitise chemo-resistant tumours

Blocking a key protein may create novel form of stress in cancer cells and re-sensitise chemo-resistant tumours

5-FU chemotherapy linked to rare brain toxicity in cancer patient

5-FU chemotherapy linked to rare brain toxicity in cancer patient

More from ecancer